Join Depymed at the LSX World Congress USA in Boston on September 13-14, 2023 – Let’s Talk Investments!

Welcome to the world of DepYmed! What is DepYmed? DepYmed, Inc. is a preclinical stage pharmaceutical company that is dedicated to developing groundbreaking treatments for rare diseases and oncology. Their focus lies on targeting the protein tyrosine phosphatase (PTP) family of enzymes. This approach sets them apart from other pharmaceutical companies and positions them as…

Read More

Unlocking the Potential: Emulsion Polymers Market Projected to Reach $42 Billion by 2027 – Transparency Market Research Reveals Exclusive Report

Emulsion Polymers Market is Anticipated to Reach US$ 42 billion by 2027, Rising at a 6.4% CAGR – Exclusive Report Wilmington, Delaware, United States, Sept. 08, 2023 (GLOBE NEWSWIRE) — Transparency Market Research Inc. Emulsification and polymerization of monomers like butadiene and styrene, as well as certain co-monomers like vinyl acetate, form emulsion polymers. The…

Read More

Revolutionizing Relief: Biorestorative Therapies Teams Up with Northwell Health for Groundbreaking Clinical Trial on Chronic Lumbar Disc Disease

BioRestorative Therapies Announces Activation of Northwell Health in the Company’s Phase 2 Clinical Trial for BRTX-100 Site Activation Brings Hope to Patients in New York Exciting news for patients in the State of New York as BioRestorative Therapies, Inc. announces the activation of Northwell Health in the Company’s Phase 2 clinical trial for BRTX-100. This…

Read More

Record-Breaking Numbers Confirmed for Token2049 Singapore: Over 10,000 Attendees and All-Star Speaker Line-Up

World’s Largest Web3 Event Hits Full Capacity Token2049: A Game Changer in the Crypto Industry Token2049, Asia’s largest crypto event, has set a new benchmark in the blockchain and cryptocurrency space by reaching full capacity with over 10,000 attendees globally, 300+ exhibitors, and 400+ side events. This esteemed event has solidified its reputation as the…

Read More